At a glance
- Originator Fujisawa
- Class Antihypertensives
- Mechanism of Action Beta-adrenergic receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 21 May 1999 New profile
- 21 May 1999 Preclinical development for Hypertension in Japan (Unknown route)